S M Haffner. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anticholesteremic Agents/therapeutic useCholesterol, HDL/bloodCoronary Disease/drug therapyCoronary Disease/epidemiologyCoronary Disease/mortalityCoronary Disease/prevention & controlDiabetic Angiopathies/drug therapyDiabetic Angiopathies/mortalityDiabetic Angiopathies/prevention & controlGemfibrozil/therapeutic useHumansHypolipidemic Agents/therapeutic useLovastatin/analogs & derivativesLovastatin/therapeutic useMulticenter Studies as TopicRandomized Controlled Trials as TopicRisk FactorsScandinavian and Nordic CountriesSimvastatinSurvival RateTriglycerides/blood
Substances: See more » Anticholesteremic AgentsCholesterol, HDLHypolipidemic AgentsTriglyceridesLovastatinSimvastatinGemfibrozil
Year: 1997 PMID: 9096961 DOI: 10.2337/diacare.20.4.469
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112